No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
Abstract Active surveillance (AS) is standard of care for patients with low-risk prostate cancer (PCa), but its feasibility in intermediate-risk patients is controversial. We compared outcomes of low- and intermediate-risk patients managed with multiparametric magnetic resonance imaging (mpMRI)-supp...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-10741-8 |